2.44
InspireMD Inc. Aktie (NSPR) Neueste Nachrichten
What analysts say about InspireMD Inc. stockRapid wealth multiplication - Autocar Professional
What drives InspireMD Inc. stock pricePhenomenal investment performance - Autocar Professional
Is InspireMD Inc. a good long term investmentConsistent triple returns - jammulinksnews.com
InspireMD Inc. Stock Analysis and ForecastAccelerated capital growth - jammulinksnews.com
How InspireMD Inc. stock performs during market volatilityShort Term Risk Controlled Alerts - Newser
InspireMD to Announce Second Quarter 2025 Financial Results - The Manila Times
InspireMD, Inc. Schedules Release of Second Quarter 2025 Financial Results and Conference Call - Quiver Quantitative
Brown Advisory Inc. Takes $27,000 Position in InspireMD, Inc. (NYSE:NSPR) - Defense World
InspireMD Shares Rise on U.S. Rollout of CGuard Prime Carotid Stent - MSN
InspireMD Launches CGuard Prime Carotid Stent System in the U.S. - MSN
What makes InspireMD Inc. stock price move sharplyInvestor Favorite Picks - Newser
Why InspireMD Inc. stock attracts strong analyst attentionFree Access to Investment Community - Newser
InspireMD Launches CGuard Prime Stent in U.S. Market - The Globe and Mail
InspireMD launches CGuard Prime carotid stent in US after FDA approval By Investing.com - Investing.com South Africa
InspireMD Launches Carotid Stent System for the Preventing Strokes - Diagnostic and Interventional Cardiology
InspireMD stock rises after US commercial launch of carotid stent system - Investing.com Nigeria
InspireMD stock rises after US commercial launch of carotid stent system By Investing.com - Investing.com South Africa
InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke - The Manila Times
InspireMD launches CGuard Prime carotid stent in US after FDA approval - Investing.com
NSPR launches CGuard Prime in U.S.; 8-K filed with Exhibit 99.1 | NSPR SEC FilingForm 8-K - Stock Titan
InspireMD, Inc.(NasdaqCM: NSPR) added to Russell 3000E Index - MarketScreener
InspireMD, Inc.(NasdaqCM: NSPR) added to Russell 3000E Value Index - MarketScreener
Why Did InspireMD Plunge 10.71% Despite FDA Approval? - AInvest
InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke - GlobeNewswire
InspireMD Gains FDA Approval for CGuard Stent System - TipRanks
InspireMD’s embolic prevention system gains CE Mark approval - Yahoo Finance
InspireMD receives CE mark approval for CGuard Prime stent system By Investing.com - Investing.com South Africa
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):